Estimated reading time: 5 minutes
Table of contents
Introduction
South Carolina’s opportunity to legalize medical cannabis is back on the legislative table in 2025. Lawmakers are revisiting reform efforts with a renewed focus on establishing a tightly regulated market that aligns with the state’s conservative approach to cannabis policy.
Legislative History and Current Proposal
State Sen. Tom Davis, R-Beaufort, reintroduced the Compassionate Care Act in January with Senate Bill 53. The proposed legislation aims to create a licensed and regulated market where qualifying patients can purchase lab-tested cannabis dispensed by pharmacists. Under this framework, patients would need to maintain closely defined relationships with their physicians to receive a diagnosis for one of the 12 qualifying conditions outlined in the bill. Additionally, the bill explicitly prohibits both smoking cannabis and growing it at home.
Davis, cosponsoring the bill with Sen. Stephen Goldfinch, R-Georgetown, has been a long-time advocate for cannabis reform in South Carolina. He previously sponsored similar versions of the Compassionate Care Act. In February 2024, a Senate-passed version of the bill received a 24-19 vote, but the proposal ultimately stalled in the House committee process due to inaction.
Challenges and Conservative Approach
The current version of the Compassionate Care Act reflects a very conservative approach to cannabis legalization—one that Davis insists is what South Carolinians want. “It is a very conservative bill because that’s what South Carolinians want,” Davis told WSPA. This cautious stance aims to address concerns by tightly controlling patient eligibility and strictly limiting consumption methods.
Davis’s earlier attempt in 2022 encountered a procedural setback when a Senate-passed version of the bill, which included a tax provision, was derailed. Under South Carolina law, revenue-raising bills must originate in the lower chamber, leading to the collapse of that version. This history of House lawmakers blocking reform efforts has left South Carolina with a “maybe” forecast for 2025. Notably, the state remains one of only eight without a medical cannabis program—even when compared to highly restrictive models like Texas’s, where THC is capped at 1%.
Conclusion
As South Carolina heads into the 2025 legislative session, the future of medical cannabis legalization remains uncertain. With the reintroduction of the Compassionate Care Act, advocates hope that a carefully tailored, conservative approach will finally break the legislative impasse. However, the history of procedural obstacles and House inaction continues to cast doubt on whether reform will ultimately prevail in the Palmetto State.
Cannabis Legalization South Carolina 2025 FAQs
There are no dispensaries in South Carolina due to the state’s prohibition of cannabis. Generally, dispensaries in legal states do not accept medical insurance for weed purchases.
CBD oil is legal for both medical and recreational use in South Carolina, although it can’t be sold as a food product. There are no legal age limits for purchasing CBD, so you can expect retailers to set age requirements at their own discretion. Most will require buyers to be over the age of 18 or 21.
Marijuana is illegal in South Carolina and cannot be delivered to residents.
Yes, Farm Bill compliant Delta 9 gummies are legal in South Carolina. You can buy Delta 9 gummies online or in-store without any restrictions, so long as they meet the following conditions: The THC must be derived from the hemp plant rather than the marijuana plant. THC concentrations must not exceed 0.3% by dry weight.
Possession of marijuana in South Carolina is classified as a misdemeanor in most cases. If you are convicted of possession of marijuana (less than one ounce), the penalty for the first offense is a $650 fine and up to 30 days in jail.
Qualifying for the medical marijuana program in South Carolina is simple. Patience must have a qualifying condition and a written certification issued by a doctor that has completed a full assessment of the patient’s medical history and current medical conditions.
Marijuana is illegal for recreational and medical purposes in South Carolina, and the use of CBD oil is only permitted for qualifying patients suffering from chronic seizures caused by epilepsy.
Additional Resources
Free eBooks For Cannabis Business Success
Latest Articles
- The Fiduciary Mandate: Why an Owner’s Rep is the Key to 2026 Cannabis Retail Success
In the cannabis retail landscape of 2026, the era of “opening at any cost” has ended. As capital markets remain disciplined and consumer margins tighten, the difference between a profitable dispensary and a “zombie project” is determined during the buildout phase. - Open a Cannabis Consumption Lounge in New Jersey: 2026 Guide to Compliance and Success
As of April 2026, the New Jersey cannabis market has matured into a sophisticated $4 billion powerhouse. The initial “novelty” phase has passed, and the industry is now defined by “Hospitality 2.0,” where consumption areas are becoming social anchors for local tourism in hubs like Atlantic City, Newark, and Jersey City. - New York Cannabis Lounge License: Expert Guide to Compliance and Success
The New York cannabis industry has transitioned from a volatile implementation phase into a “Pharma-Grade” era of structural maturity. As of April 2026, the state has reached a monumental economic milestone, with total reported retail sales officially surpassing $3,000,000,000. For entrepreneurs, the current frontier is the “social hospitality” sector, which is defined by high-stakes technical compliance and rigorous municipal negotiation. - The 2026 New York Execution Gap: Scaling Your Cannabis Business
The trajectory of the New York cannabis industry has transitioned from a period of experimental regulation to one of massive commercial consolidation and operational intensity. As of April 15, 2026, the state has officially matured into its role as the second-largest cannabis market in the United States, trailing only California in total economic activity and consumer demand. The primary indicator of this success is the milestone reached in early 2026, where total reported retail sales since the inception of the legal program surpassed $2.97 billion. - Regulatory Maturity and Market Dynamics: A Comprehensive Analysis of the New Jersey Cannabis Industry
The legal landscape of cannabis in New Jersey has transitioned from a period of rapid legislative enactment into an era of complex regulatory maturity and secondary market correction. Since the foundational passage of the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA) in early 2021, the state has systematically dismantled the architecture of prohibition while constructing a highly regulated, billion-dollar industry. - Nebraska Medical Cannabis Market Strategic Report: Navigating the Regulatory Landscape and Licensing Framework 2026
The Nebraska medical cannabis industry has undergone a radical transformation from its nascent beginnings in the 2024 general election to the highly structured, albeit restrictive, regulatory environment of April 2026. This period has been characterized by intense legislative maneuvering, high-stakes licensing competitions, and a fundamental shift in the state’s administrative approach to controlled substances.